Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. (Q47979432)

7 February 2018

title

Transforming growth factor-beta1 in autoimmune hepatitis: correlation of liver tissue expression and serum levels with disease activity. (English)

1 reference

7 February 2018

1 reference

Bayer EM

1

1 reference

7 February 2018

Herr W

2

1 reference

7 February 2018

Kanzler S

3

1 reference

7 February 2018

Waldmann C

4

1 reference

7 February 2018

Meyer Zum Büschenfelde KH

5

1 reference

7 February 2018

Dienes HP

6

1 reference

7 February 2018

Lohse AW

7

1 reference

7 February 2018

publication date

1 May 1998

1 reference

7 February 2018

published in

Journal of Hepatology

1 reference

7 February 2018

volume

28

1 reference

7 February 2018

issue

5

1 reference

7 February 2018

page(s)

803-811

1 reference

7 February 2018

Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

The natural course and heterogeneity of autoimmune-type chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Autoimmunity and liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Physiological actions and clinical applications of transforming growth factor-beta (TGF-beta).

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Protective effect of transforming growth factor beta 1 on experimental autoimmune diseases in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Transforming growth factor beta 1 suppresses acute and chronic arthritis in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Meeting report: International Autoimmune Hepatitis Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Increased transforming growth factor-beta 1 gene expression in human liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Ito-cell gene expression and collagen regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4,

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

The nature and prognosis of severe cryptogenic chronic active hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2898%2980230-4

7 January 2021

10.1016/S0168-8278(98)80230-4

Identifiers

DOI

1 reference

7 February 2018

PubMed ID

9625315

1 reference

7 February 2018